Telomerase Inhibition and Cancer: Might Platinum Based Drugs have a Future as Anti-telomerase Pharmacological Approach?

E-ISSN： 1875-533x|12|26|3091-3102

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.12, Iss.26, 2005-12, pp. : 3091-3102

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Telomerase Inhibition in Cancer Therapeutics: Molecular-Based Approaches

Current Medicinal Chemistry, Vol. 13, Iss. 24, 2006-10 ,pp. : 2875-2888

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Telomerase by Antisense-Based Approaches: Perspectives for New Anti-Cancer Therapies

Current Pharmaceutical Design, Vol. 11, Iss. 9, 2005-04 ,pp. : 1105-1117

Bentham Science Publishers

Access to resources Recommend Favorite

Telomerase inhibition and telomere erosion: a two-pronged strategy in cancer therapy

By Odago F.O. Gerson S.L.

Trends in Pharmacological Sciences, Vol. 24, Iss. 7, 2003-07 ,pp. : 328-331

Elsevier

Access to resources Recommend Favorite

Telomerase Modulation in Therapeutic Approach

Current Pharmaceutical Design, Vol. 20, Iss. 41, 2014-12 ,pp. : 6438-6451

Bentham Science Publishers

Access to resources Recommend Favorite

DNA Tetraplex-Binding Drugs Structure-Selective Targeting is Critical for Antitumour Telomerase Inhibition

Mini Reviews in Medicinal Chemistry, Vol. 1, Iss. 1, 2001-05 ,pp. : 31-41

Bentham Science Publishers

Access to resources Recommend Favorite